These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 37311212)
1. Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity. Yang M; Zinkgraf M; Fitzgerald-Cook C; Harrison BR; Putzier A; Promislow DEL; Wang AM G3 (Bethesda); 2023 Aug; 13(9):. PubMed ID: 37311212 [TBL] [Abstract][Full Text] [Related]
2. Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease. Gao S; Casey AE; Sargeant TJ; Mäkinen VP Brain; 2018 Sep; 141(9):2711-2720. PubMed ID: 30124770 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. Deming Y; Li Z; Kapoor M; Harari O; Del-Aguila JL; Black K; Carrell D; Cai Y; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Huang KL; Bertelsen S; Fagan AM; Holtzman DM; Morris JC; Kim S; Saykin AJ; De Jager PL; Albert M; Moghekar A; O'Brien R; Riemenschneider M; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Schellenberg G; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Peskind ER; Li G; Di Narzo AF; ; ; Kauwe JS; Goate AM; Cruchaga C Acta Neuropathol; 2017 May; 133(5):839-856. PubMed ID: 28247064 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study. Han MR; Schellenberg GD; Wang LS; BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310 [TBL] [Abstract][Full Text] [Related]
5. A data-driven study of Alzheimer's disease related amyloid and tau pathology progression. Aksman LM; Oxtoby NP; Scelsi MA; Wijeratne PA; Young AL; Alves IL; Collij LE; Vogel JW; Barkhof F; Alexander DC; Altmann A; Brain; 2023 Dec; 146(12):4935-4948. PubMed ID: 37433038 [TBL] [Abstract][Full Text] [Related]
6. Amyloid, tau and risk of Alzheimer's disease: a Mendelian randomization study. Yeung CHC; Lau KWD; Au Yeung SL; Schooling CM Eur J Epidemiol; 2021 Jan; 36(1):81-88. PubMed ID: 32929646 [TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort. Chen D; Li J; Liu H; Liu X; Zhang C; Luo H; Wei Y; Xi Y; Liang H; Zhang Q Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510227 [TBL] [Abstract][Full Text] [Related]
17. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models. Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827 [TBL] [Abstract][Full Text] [Related]
18. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease. Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338 [TBL] [Abstract][Full Text] [Related]
19. Transgenic Drosophila models of Alzheimer's disease and tauopathies. Iijima-Ando K; Iijima K Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412 [TBL] [Abstract][Full Text] [Related]
20. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]